The Cheaper, Costlier List: Details Here
With reduction in custom duty on cancer drug and mobile phones, their prices are estimated to contract considerably. The three drugs to see reduction on custom duty are Trastuzumab deruxtecan, Osimertinib and Durvalumab.
